Tianjin set up the center of pharmaceutical innovation to speed up the research and development of new drugs

Xinhua news agency, Tianjin, July 2 (reporter Mao Zhenhua) Tianjin pharmaceutical clinical research technology innovation center was officially established recently In the future, the center will aim at the pain point of clinical research, and accelerate the pace of new drug listing by building innovative technology platform and integrating industry advantage resources Tianjin pharmaceutical clinical research technology innovation center is established with the support of Tianjin Science and Technology Bureau and other government departments It is led by kailaiying, a pharmaceutical enterprise engaged in pharmaceutical R & D, production and customization, and is responsible for daily operation It is understood that the center will focus on clinical research of innovative drugs, validation clinical research of generic drugs, post marketing pharmacoeconomics research based on real world data and other businesses, provide services in experimental design, biological sample analysis, data management and other aspects with innovative models and technologies, and provide one-stop innovation services of the whole industry chain for clinical research of drugs Yang Rui, director of the center and chief operating officer of kailaiying, said that according to statistics, the problems of insufficient design capacity of original clinical trials of new drugs in China, low efficiency and reliability of test data collection are more prominent After the establishment of the center, we will aim at these pain points, reshape the clinical trial process and quality standards, which is expected to significantly improve the quality of clinical trials in various stages, shorten the trial cycle and speed up new trials The pace of drug development and marketing "Technological innovation is the driving force of economic growth." Zu Yanhui, deputy director of Tianjin Science and Technology Bureau, said the center was one of the first four innovation centers being set up in Tianjin, focusing on innovation in the field of clinical drug research Through the integration of Tianjin's advantageous resources, and by innovative means to improve the clinical evaluation ability of new drugs, Tianjin has been promoted to become an important gathering place for new drug research and development projects (end) this article is the reprinted content of yaozhi.com The copyright belongs to the original author The purpose of reprinting is to transmit more information and does not represent the view of this platform If the content of the work, copyright and other issues are involved, please contact our website message, we will delete the content in the first time.